GWM
GH icon

Gibbs Wealth Management’s Guardant Health GH Stock Holding History

Gibbs Wealth Management’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Buy
+5,935
New +$596K 0.07% 265

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Gibbs Wealth Management's GH Position: Q1 2026 in Review

Gibbs Wealth Management opened a new position in Guardant Health (GH) in Q1 2026: 5,935 shares worth $548K. The stake represents 0.07% of the portfolio and ranks #265 among its holdings.

486 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Gibbs Wealth Management held 5,935 shares of Guardant Health worth $548K as of Q1 2026.
  • Guardant Health was a new Gibbs Wealth Management position in Q1 2026.
  • Guardant Health made up 0.07% of Gibbs Wealth Management's portfolio in Q1 2026, its #265 holding.
  • 486 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.